The Ministry of Health and Welfare and the Ministry of SMEs and Startups anunció a 'full-cycle colaboración plan to systematically apoyo the crecimiento and expansión global of pharmaceutical bio-ventures.'
Package apoyo se proporcionará from inversión, I+D, and clinical entry to expansión global to nurture venture candidatos esperado to create blockbuster drugs with anual sales exceeding $1 billion. At the policy discussion, a '4UP Strategy' focusing on scale-up, open innovación, ecosystem strengthening, and field colaboración was adopted.
Industry voices called for a 'virtuous cycle ecosystem between bio-ventures and empresas farmacéuticas,' with key requests including addressing regional empresas' limitations in attracting venture capital, improving regulations for new modalities, and easing listing maintenance requirements. Strategic utilization to respond to the rapid crecimiento of China's bio mercado was also discutió.
